Both in Pharmaceuticals
Citius Oncology vs Genelux
Over the past year CTOR returned −48.3% and GNLX returned −42.4%; their daily moves had a correlation of 0.12.
CTOR −48.3% GNLX −42.4%Growth of $1, one year, split-adjusted
| Metric | CTOR | GNLX |
|---|---|---|
| Price | $1.05 | $2.45 |
| Market cap | $111.0M | $110.9M |
| Today | +1.94% | −0.81% |
| 1 month | +35.4% | −7.9% |
| 6 months | +113.0% | +6.5% |
| Year to date | +5.0% | −43.8% |
| 1 year | −47.5% | −41.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | 67.1% | — |
| Net margin | −597.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 15.6× | 13,856.4× |
| Net cash | $10.2M | $18.7M |
| Dividend yield | — | — |
| Volatility (60d) | 99.9% | 53.7% |
| Short % of float | 1.9% | 10.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).